Sti Innovations

symptom targeted intervention (or sti) is a proprietary program created in 2010 to help patients improve clinical outcomes and engage more in their healthcare. since then, sti has been rolled out to over 5000 clinics and hospitals across the us, uk, and canada. research suggests that it decrease depression, missed treatments, hospitalizations and anxiety and increases quality of life score and patient engagement . sti is being used by kaiser permanente, davita, fmc, among others and saves an average of $2-14k per patient per year due to improved treatment adherence and decreased hospitalization rates. we are 85% penetrated in us renal clinics, and are scaling our program to other clinical contexts such as chronic care management and hospital readmission prevention. we have active pilot programs with 3 university hospitals and 2 private hospital chains to test new clinical applications of sti. our revenue is derived from a combination of licensing fees, implementation consulting, and ph